| Name | Title | Contact Details |
|---|---|---|
Rachel Stahler |
Chief Information Officer | Profile |
OSO BioPharmaceuticals Manufacturing is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Metabolic Solutions Development Company, LLC (MSDC) discovers and develops novel molecular targets and new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company has raised nearly $55 million in support of the development of its novel therapeutic drugs, MSDC-0160 and MSDC-0602, which selectively modulate mitochondrial control of to important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, that are out of balance in patients with type 2 diabetes. Such imbalances may also play a role in other diseases of aging such as Alzheimer’s disease and Parkinson’s disease, as well certain genetic diseases such as polycystic kidney disease.
BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to h...
Arro Corporation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Therapeutic and Educational Services Provider